Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Baxter
McKesson
Colorcon
Express Scripts
Argus Health
Teva
Farmers Insurance
Healthtrust

Generated: April 26, 2018

DrugPatentWatch Database Preview

Avobenzone; ecamsule; octocrylene - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for avobenzone; ecamsule; octocrylene and what is the scope of avobenzone; ecamsule; octocrylene patent protection?

Avobenzone; ecamsule; octocrylene
is the generic ingredient in four branded drugs marketed by Loreal Usa and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for avobenzone; ecamsule; octocrylene. One supplier is listed for this compound.
Summary for avobenzone; ecamsule; octocrylene

US Patents and Regulatory Information for avobenzone; ecamsule; octocrylene

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Loreal Usa ANTHELIOS 40 avobenzone; ecamsule; octocrylene; titanium dioxide CREAM;TOPICAL 022009-002 Oct 29, 2009 OTC Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Loreal Usa ANTHELIOS 40 avobenzone; ecamsule; octocrylene; titanium dioxide CREAM;TOPICAL 022009-001 Mar 31, 2008 OTC Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Loreal Usa CAPITAL SOLEIL 15 avobenzone; ecamsule; octocrylene CREAM;TOPICAL 021501-001 Oct 2, 2006 OTC Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Loreal Usa ANTHELIOS 20 avobenzone; ecamsule; octocrylene; titanium dioxide CREAM;TOPICAL 021471-001 Oct 5, 2006 OTC Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for avobenzone; ecamsule; octocrylene

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Loreal Usa ANTHELIOS SX avobenzone; ecamsule; octocrylene CREAM;TOPICAL 021502-001 Jul 21, 2006 ➤ Sign Up ➤ Sign Up
Loreal Usa ANTHELIOS SX avobenzone; ecamsule; octocrylene CREAM;TOPICAL 021502-001 Jul 21, 2006 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
US Department of Justice
Cerilliant
Daiichi Sankyo
UBS
Cantor Fitzgerald
Mallinckrodt
Merck
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.